Updates to the HPV Section of the Adult and Adolescent Opportunistic Infections Guidelines

Read the full article.

The Human Papillomavirus Disease (HPV) section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents has been updated. The Panel updated the recommendation on HPV vaccination in females and males with HIV infection ages 13 to 26 years to the 9-valent HPV recombinant vaccine (0.5 ml at 0, 1 to 2, and 6 months) (AIII). For patients who have completed a vaccination series with the recombinant bivalent or quadrivalent vaccines, many experts would give an additional full series of the 9-valent recombinant vaccine (CIII).


Date Imported: November 29, 2018